Incidence of diabetes among postmenopausal breast cancer survivors

Diabetologia

Volumn 56, Issue 3, 2013, Pages 476-483

  Lipscombe, L L ^a,b,c,d   Chan, W W ^a   Yun, L ^c   Austin, P C ^c,d   Anderson, G M ^c,d   Rochon, P A ^a,b,c,d  

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Adjuvant chemotherapy; Breast cancer; Diabetes mellitus; Epidemiology

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; POSTMENOPAUSE; SURVIVORS;

EID: 84878363340     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2793-9     Document Type: Article

References (24)

1. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856-862
2. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Canc Res Treat 98:349-356
3. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2008) The impact of diabetes on survival following breast cancer. Breast Canc Res Treat 109:389-395
4. Peairs KS, Barone BB, Snyder CF et al (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 29:40-46
5. Lipscombe LL (2011) Insulin, insulin resistance, and cancer associations. In: Fantus IG (ed) Insulin resistance and cancer. Springer, New York, pp 111-140
6. Godsland IF (2010) Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond) 118:315-332
7. Simon D, Balkau B (2010) Diabetes mellitus, hyperglycaemia and cancer. Diabetes Metab 36:182-191
8. Lipscombe LL, Fischer HD, Yun L et al (2012) Association between tamoxifen treatment and diabetes: a population-based study. Cancer 118:2615-2622
9. Bordeleau L, Lipscombe L, Lubinski J et al (2011) Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations. Cancer 117:1812-1818
10. McCarthy NJ (2004) Care of the breast cancer survivor: increased survival rates present a new set of challenges. Postgrad Med 116: 39-40, 42, 45-36
11. Robles SC, Marrett LD, Clarke EA, Risch HA (1988) An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol 41:495-501
12. Hux JE, Ivis F, Flintoft V, Bica A (2002) Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25:512-516
13. Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R (1987) Factors influencing the age at natural menopause. J Chronic Dis 40:995-1002
14. Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619
15. Goldhirsch A, Glick JH, Gelber RD et al (2005) Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 16:1569-1583
16. Noto H, Tsujimoto T, Sasazuki T, Noda M (2011) Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis. Endocr Pract 17:616-628
17. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Increased prevalence of prior breast cancer in women with newly diagnosed diabetes. Breast Canc Res Treat 98:303-309
18. Goodwin PJ, Ennis M, Pritchard KI et al (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42-51
19. Carr MC (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88:2404-2411
20. Oyer DS, Shah A, Bettenhausen S (2006) How to manage steroid diabetes in the patient with cancer. J Support Oncol 4:479-483
21. Hickish T, Astras G, Thomas P et al (2009) Glucose intolerance during adjuvant chemotherapy for breast cancer. J Natl Cancer Inst 101:537
22. Walker ED (1988) Hyperglycemia. A complication of chemotherapy in children. Canc Nurs 11:18-22
23. Ellis ME, Weiss RB, Korzun AH et al (1986) Hyperglycemic complications associated with adjuvant chemotherapy of breast cancer. A cancer and leukemia group B (CALGB) study. Am J Clin Oncol 9:533-536
24. Moride Y, Abenhaim L (1994) Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research. J Clin Epidemiol 47:731-737